Dupilumab is safe and efficacious in treating moderate-to-severe AD in pediatric patients.

The Canadian Dermatology Association, in collaboration with the Acne and Rosacea Society of Canada, has issued a joint position...

Gene therapy for genodermatoses is a rapidly evolving field of research with the potential to greatly improve patient quality of life....

Guselkumab is efficacious in patients with moderate-to-severe psoriasis and a history of cancer.

Deciphering and modifying the composition of various gut bacteria may improve immune checkpoint blockade (ICB) treatment responses in...

The Women in Dermatology Honour Roll recognizes female dermatologists in Canada who have made significant contributions to the specialty...

Lutikizumab 300 mg was shown to be more effective than placebo in HS patients.

A new study from Northwestern University in Chicago has identified a concerning trend in the accuracy of skin disease diagnosis across...